Provided by Tiger Trade Technology Pte. Ltd.

Tenon Medical, Inc.

6.83
-0.2400-3.39%
Post-market: 6.46-0.3700-5.42%19:59 EDT
Volume:560.87K
Turnover:3.91M
Market Cap:4.56M
PE:-0.15
High:7.50
Open:7.20
Low:6.35
Close:7.07
52wk High:54.95
52wk Low:4.38
Shares:667.00K
Float Shares:620.74K
Volume Ratio:0.04
T/O Rate:90.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-46.7185
EPS(LYR):-394.1968
ROE:-551.19%
ROA:-71.98%
PB:-0.95
PE(LYR):-0.02

Loading ...

Jul 28, 2023

Major Issues Report

Form 8-K - Current report
Jul 22, 2023

Major Issues Report

Form 8-K - Current report
Jul 18, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jul 11, 2023

Major Issues Report

Form 8-K - Current report
Jun 20, 2023

Major Issues Report

Form 8-K - Current report
Jun 07, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
May 19, 2023

Major Issues Report

Form 8-K - Current report
May 16, 2023

Correspondence

Form CORRESP - Correspondence
May 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 10, 2023

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 09, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 08, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 15, 2022

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 10, 2022

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 11, 2022

Major Issues Report

Form 8-K - Current report
Aug 12, 2022

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 27, 2022

Major Issues Report

Form 8-K - Current report
Jun 09, 2022

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]